An FDA advisory committee unanimously recommended the agency approve two new antibiotics, while speakers debated the agency's approach to encouraging new drugs for drug-resistant infections.
via WSJ.com: US Business http://ift.tt/1fgEEXA
via WSJ.com: US Business http://ift.tt/1fgEEXA
Nessun commento:
Posta un commento